banner
Bcl-2 antagonist BDA-366, Purity ≥98%

Cat. No.: X23-10-ZQ014

Bcl-2 antagonist BDA-366, Purity ≥98%

Synonym: 1909226-00-1; 142645-19-0; BDA-366; BDA366; 1-[[(2S)-3-(Diethylamino)-2-hydroxypropyl]amino]-4-[[(2S)-2-oxiranylmethyl]amino]-9,10-anthracenedione; Bcl-2 antagonist

  • CAS Number: 142645-19-0
  • Compound CID: 91826545
Product Size
2 mg; 5 mg; 10 mg; 25 mg
Price
Datasheet
MSDS
Properties
Description
BDA-366 specifically inhibits the function of the anti-apoptotic proteins, thereby promoting apoptosis in cancer cells.
Molecular Weight
423.5
Molecular Formula
C24H29N3O4
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
BDA-366 can be used to modulate of Bcl-2 family proteins to assess cancer cell sensitivity.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

  • SUITE 201, 17 Ramsey Road, Shirley, NY 11967, USA
  • 1-631-637-6119
Copyright © 2025 CD BioGlyco. All rights reserved.
0
There is no product in your cart.

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x